A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.

Ahmed J, Knisely A, Torrado C, Stephen B, Yang Y, Song J, Alshawa A, Zarifa A, Jhingran A, Koay EJ, Morris VK, Javle M, Wolff RA, Meric-Bernstam F, Pant S, Rodon J, Naing A

Open source

DOI: 10.1093/oncolo/oyaf032
Published: 2025 Mar 10
Container: The oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf032,
  title = {A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.},
  author = {Ahmed J and Knisely A and Torrado C and Stephen B and Yang Y and Song J and Alshawa A and Zarifa A and Jhingran A and Koay EJ and Morris VK and Javle M and Wolff RA and Meric-Bernstam F and Pant S and Rodon J and Naing A},
  year = {2025},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyaf032},
  url = {https://doi.org/10.1093/oncolo/oyaf032}
}

RIS

TY  - JOUR
TI  - A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.
AU  - Ahmed J
AU  - Knisely A
AU  - Torrado C
AU  - Stephen B
AU  - Yang Y
AU  - Song J
AU  - Alshawa A
AU  - Zarifa A
AU  - Jhingran A
AU  - Koay EJ
AU  - Morris VK
AU  - Javle M
AU  - Wolff RA
AU  - Meric-Bernstam F
AU  - Pant S
AU  - Rodon J
AU  - Naing A
PY  - 2025
JO  - The oncologist
DO  - 10.1093/oncolo/oyaf032
UR  - https://doi.org/10.1093/oncolo/oyaf032
ER  -

APA

J, A., A, K., C, T., B, S., Y, Y., J, S., A, A., A, Z., A, J., EJ, K., VK, M., M, J., RA, W., F, M., S, P., J, R., & A, N. (2025). A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.. The oncologist. https://doi.org/10.1093/oncolo/oyaf032

Source records

pubmed · retrieved 2026-09-25T04:02:41.357Z